Literature DB >> 1679356

Enzymic control of the expression of the X determinant (CD15) in human myeloid cells during maturation: the regulatory role of 6-sialytransferase.

P O Skacel1, A J Edwards, C T Harrison, W M Watkins.   

Abstract

To establish the basis for the reduced expression of the X determinant on leukemic blasts and the changes in antigenic expression that occur during myeloid maturation, the presence on myeloid cells of X and related structures was examined in conjunction with studies on the activities of the glycosyltransferases involved in their biosynthesis. Expression of X and sialyl-X was weak on blasts in comparison with neutrophils despite the presence of the requisite precursor structures. Much higher levels of 3-fucosyltransferase activity were found in blasts than in neutrophils when nonsialylated substrates were used, but, whereas the enzyme in neutrophils reacted equally well with 3'-sialylated and nonsialylated acceptors, the enzyme in blasts showed a marked preference for nonsialylated substrates. 6'-Sialyltransferase activity was strong in blasts but was not detectable in neutrophils, whereas a much lower level of 3'-sialyltransferase activity was present in both blasts and neutrophils. Dimethyl sulfoxide-induced maturation of HL60 cells was associated with (1) a decrease in both 6'-sialyltransferase and 3-fucosyltransferase activities, (2) a change in the substrate specificity of 3-fucosyltransferase towards that found in mature cells, and (3) increased cell surface expression of sialyl-X. These results suggest that the reduced expression of X in myeloblasts is related to the presence of the strong 6'-sialyltransferase, which uses the precursor substrate at the expense of the 3-fucosyltransferase and prevents the synthesis of X and sialyl-X. The developmental regulation of the levels of 3'- and 6'-sialyltransferases, and the level and specificity of the 3-fucosyltransferases, therefore controls the expression of X and its degree of sialylation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679356

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

Review 1.  Sialyltransferases in cancer.

Authors:  F Dall'Olio; M Chiricolo
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

2.  Second Jenner international glycoimmunology meeting.

Authors: 
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

3.  Altered expression of sialylated glycoproteins in breast cancer using hydrazide chemistry and mass spectrometry.

Authors:  Yuan Tian; Francisco J Esteva; Jin Song; Hui Zhang
Journal:  Mol Cell Proteomics       Date:  2012-02-07       Impact factor: 5.911

4.  Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells.

Authors:  Amanda F Swindall; Susan L Bellis
Journal:  J Biol Chem       Date:  2011-05-05       Impact factor: 5.157

5.  Heterogeneity in Lewis-X and sialyl-Lewis-X antigen expression on monocytes in whole blood: relation to stimulus-induced oxidative burst.

Authors:  C Elbim; J Hakim; M A Gougerot-Pocidalo
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

Review 6.  The sialyl-alpha2,6-lactosaminyl-structure: biosynthesis and functional role.

Authors:  F Dall'Olio
Journal:  Glycoconj J       Date:  2000-10       Impact factor: 2.916

7.  Expression of sialyltransferase activity on intact human neutrophils.

Authors:  Salahaldin Rifat; Tae Jin Kang; Dean Mann; Lei Zhang; Adam C Puche; Nicholas M Stamatos; Simeon E Goldblum; Reinhard Brossmer; Alan S Cross
Journal:  J Leukoc Biol       Date:  2008-07-29       Impact factor: 4.962

8.  Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms.

Authors:  Faheem M Shaikh; Eric C Seales; William C Clem; Kristin M Hennessy; Ya Zhuo; Susan L Bellis
Journal:  Exp Cell Res       Date:  2008-07-30       Impact factor: 3.905

9.  Glycosyltransferase and sulfotransferase gene expression profiles in human monocytes, dendritic cells and macrophages.

Authors:  François Trottein; Lana Schaffer; Stoyan Ivanov; Christophe Paget; Catherine Vendeville; Aurélie Cazet; Sophie Groux-Degroote; Suzanna Lee; Marie-Ange Krzewinski-Recchi; Christelle Faveeuw; Steven R Head; Philippe Gosset; Philippe Delannoy
Journal:  Glycoconj J       Date:  2009-12       Impact factor: 2.916

10.  Sialyl Lewis(x) epitopes do not occur on acute phase proteins in mice: relationship to the absence of alpha3-fucosyltransferase in the liver.

Authors:  E C Havenaar; R C Hoff; D H van den Eijnden; W van Dijk
Journal:  Glycoconj J       Date:  1998-04       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.